Author

Z. A. Rizvi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 5 Organism:mouse· 4 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:development & morphogenesis· 1

Frequent Co-Authors

A. Awasthi· 5 shared M. R. Tripathy· 3 shared S. Mani· 3 shared S. Sadhu· 3 shared G. R. Medigeshi· 2 shared J. Dandotiya· 2 shared M. Dikshit· 2 shared S. Goswami· 2 shared

Activity by Year

2021-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersImmunology

A. Awasthi

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis.

Z. A. Rizvi, P. Babele, S. Sadhu, U. Madan, M. R. Tripathy, S. Goswami, S. Mani, S. Kumar, A. Awasthi, M. Dikshit

This study shows that Glycyrrhiza glabra extract reduces inflammation and lung damage in hamsters infected with SARS-CoV-2 by lowering pro-inflammatory cytokines and NETosis.

bioRxiv · May 16, 2022Immunology

SARS-CoV-2 and its variants, but not Omicron, induces thymic atrophy and impaired T cell development

Z. A. Rizvi, S. Sadhu, J. Dandotiya, A. Binayke, P. Sharma, V. Singh, V. Das, R. Khatri, R. Kumar, S. Samal, M. Kalia, A. Awasthi

This study shows SARS-CoV-2 and its variants cause thymic atrophy and impair T cell development, with Omicron having a lesser effect than Delta.

bioRxiv · Apr 7, 2022 · PreprintImmunology

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 delta variant

N. Hingankar, S. Deshpande, P. Das, Z. A. Rizvi, A. Burns, S. Barman, F. Zhao, M. Y. Ansari, S. Mukherjee, J. L. Torres, S. Chattopadhyay, F. Mehdi, J. Sutar, D. K. Rathore, K. Pargai, , J. Bhattacharya

This paper identifies two potent monoclonal antibodies from an Indian donor that neutralize SARS-CoV-2 variants including Delta, showing protection in a mouse model.

bioRxiv · Dec 25, 2021Immunology

Effect of prophylactic use of intra-nasal oil formulations in the hamster model of Covid-19

Z. A. Rizvi, M. R. Tripathy, N. Sharma, S. Goswami, N. Srikanth, J. Shastry, S. Mani, M. Surjit, A. Awasthi, M. Dikshit

The paper evaluates two intra-nasal oil formulations in a hamster model of SARS-CoV-2 infection, finding that Anu oil reduces viral load, body weight loss, and lung pathology compared to the control.

bioRxiv · Jun 25, 2021Microbiology

Immunological and cardio-vascular pathologies associated with SARS-CoV-2 infection in golden syrian hamster

Z. A. Rizvi, R. Dalal, S. Sadhu, Y. Kumar, T. Shrivastava, S. K. Gupta, S. Aggarwal, M. R. Tripathy, A. K. Yadav, G. R. Medigeshi, A. K. Pandey, S. Samal, S. Asthana, A. Awasthi

This study shows that SARS-CoV-2 infection in golden Syrian hamsters causes lung and cardiovascular pathologies similar to human COVID-19, suggesting GSH as a model for studying long-term effects.

bioRxiv · Jan 11, 2021Microbiology